Original articleApplication of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy
References (15)
- et al.
IS6110: conservation of sequence in the Mycobaterium tuberculosis complex and its utilization in DNA fingerprinting
Mol Cell Probes
(1991) Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong
Tubercle
(1975)- et al.
Specimen cross-contamination by a strain of Mycobacterium tuberculosis lacking nitrate reductase activity
Diagn Microboil Infect Dis
(1991) - et al.
Quality control in tuberculosis bacteriology 1. Laboratory studies on isolated positive cultures and the efficiency of direct smear examination
Tubercle
(1980) - et al.
Quality control in tuberculosis bacteriology 2. The origin of isolated positive cultures from the sputum of patients in four studies of short course chemotherapy in Africa
Tubercle
(1980) Mycobacteriophages and phage typing
Ann Microbiol
(1978)- et al.
Phage typing of mycobacteria
Cited by (75)
Recurrent tuberculosis in patients infected with the predominant Mycobacterium tuberculosis outbreak strain in Denmark. New insights gained through whole genome sequencing
2020, Infection, Genetics and EvolutionCitation Excerpt :High relapse rates indicate problems during treatment (Luzze et al., 2013), whereas high rates of reinfection have implications for TB control measures. Since the early 1990s, it has been possible to assess the magnitude of reinfection versus relapse by applying genotyping techniques (Das et al., 1993; Hawken et al., 1993), with two methods comparing specific parts of the genome (Restriction Fragment Length Polymorphism (RFLP) and Mycobacterial Interspersed Repetitive Units - Variable Number of Tandem Repeats (MIRU-VNTR)) (Dobler et al., 2008; Witney et al., 2017). If two isolates from a patient shared the same genotype, the conclusion was relapse, if different, reinfection (Bang et al., 2010; Bryant et al., 2013; Guerra-Assunção et al., 2014).
Challenges and controversies in the treatment of spinal tuberculosis
2020, Journal of Clinical Tuberculosis and Other Mycobacterial DiseasesCitation Excerpt :The treatment often involves using a number of drugs in combination for a long duration, especially in extrapulmonary TB where the challenge lies in trying to destroy this dormant subpopulation once they start replicating [10]. While exogenous reinfection can cause recurrence in high endemic areas [12,13] inadequate killing of these endogenous dormant bacteria can also lead to relapse [13–15]. The duration of treatment in osseous TB can be unusually prolonged, up to a year or two which makes clinical trials investigating relapse-free cure rates extremely difficult.
Exogenous reinfection in tuberculosis
2005, Lancet Infectious DiseasesRecurrence in tuberculosis: Relapse or reinfection?
2003, Lancet Infectious DiseasesCitation Excerpt :Most studies report on recurrences after treatment of the first tuberculosis episode with rifampicin-containing regimen. The earlier studies18–20 report on recurrences after treatment without rifampicin. Das et al21 give no details on the regimens used.
Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains
2002, Trends in MicrobiologyEnd Point of Chemotherapy for TB Spine?
2022, Tuberculosis of the Spine